MIR573 Gene

HGNC Family Non-coding RNAs
Name microRNA 573
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐573 (miR‐573) has emerged as a critical regulator in diverse malignancies. In melanoma, reduced miR‐573 levels lead to enhanced expression of melanoma cell adhesion molecule (MCAM), thereby facilitating tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In gastric and pancreatic cancers, miR‐573 directly targets TSPAN1 to suppress cell proliferation, invasion, and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In prostate cancer, its downregulation is correlated with increased fibroblast growth factor receptor 1 (FGFR1) expression and enhanced epithelial–mesenchymal transition, promoting metastasis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", while in hepatocellular carcinoma, overexpression of miR‐573 suppresses apolipoprotein M (apoM), reducing apoptosis via modulation of Bcl2A1 and ultimately favoring tumor growth."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, miR‐573 modulates ARHGAP26 expression through its 3′‐UTR, where ADAR1‐mediated A‐to‐I RNA editing prevents miR‐573 binding and affects RhoA activity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its roles in solid tumors, miR‐573 contributes to the orchestration of angiogenic and proliferative signaling in various cancer subtypes and inflammatory conditions. In familial breast cancers, downregulation of miR‐573 is linked to disturbances in focal adhesion, VEGF, and HIF‐1 signaling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In cervical and non‐small cell lung cancers, competing endogenous RNAs—such as lncRNA TTN‐AS1 and FLVCR1‐AS1—sequester miR‐573, which normally represses oncogenic E2F3, thereby promoting cell proliferation and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " A similar sponging mechanism is observed in breast cancer, where SNHG1 reduces miR‐573 levels to increase LMO4 expression and drive oncogenic behavior."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " In rheumatoid arthritis, miR‐573 directly targets TXNDC5—and novel targets such as EGFR and TLR2—to inhibit key inflammatory mediators and angiogenic factors, thereby exerting a protective effect against joint inflammation and vascular remodeling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenesis and inflammation, miR‐573 plays important roles in tissue homeostasis and vascular integrity. Its function in intervertebral disc biology has been probed, with investigations suggesting a protective role in degenerative nucleus pulposus cells."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Moreover, during dengue virus infection, miR‐573 is significantly downregulated in endothelial cells—a change associated with increased ANGPT2 expression and vascular permeability; restoration of miR‐573 mitigates endothelial dysfunction by suppressing ANGPT2 and dampening TLR2‐mediated inflammatory interferon responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Finally, emerging research into circRNA regulation in melanoma further highlights the intricate non‐coding RNA networks within which miR‐573 operates."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Collectively, these findings establish miR‐573 as a multifaceted regulator that can function as a tumor suppressor or, in certain contexts, contribute to tumor progression and inflammatory pathology by modulating diverse signaling pathways.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "He-Fei Wang, Hong Chen, Min-Wang Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2451"}], "href": "https://doi.org/10.3892/or.2013.2451"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23670160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23670160"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhengmao Lu, Tianhang Luo, Mingming Nie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.05.044"}], "href": "https://doi.org/10.1016/j.febslet.2015.05.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26054975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26054975"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Lei Wang, Peng Gao, Ping Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Strahlenther Onkol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00066-020-01728-3"}], "href": "https://doi.org/10.1007/s00066-020-01728-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33320287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33320287"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Lin Wang, Guanhua Song, Weiwei Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5427"}], "href": "https://doi.org/10.18632/oncotarget.5427"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26451614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26451614"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yan-Wei Hu, Zhi-Ping Chen, Xiu-Mei Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Apoptosis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10495-015-1153-x"}], "href": "https://doi.org/10.1007/s10495-015-1153-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26201458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26201458"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Qiong Wang, Haipeng Hui, Zhendong Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1261/rna.041533.113"}], "href": "https://doi.org/10.1261/rna.041533.113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24067935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24067935"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Katia Danza, Simona De Summa, Rosamaria Pinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.2509"}], "href": "https://doi.org/10.18632/oncotarget.2509"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25333258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25333258"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ping Chen, Rui Wang, Qingfen Yue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.08.077"}], "href": "https://doi.org/10.1016/j.bbrc.2018.08.077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30135013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30135013"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xinyuan Gao, Shasha Zhao, Xiaohua Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FLVCR1-AS1 contributes to the proliferation and invasion of lung cancer by sponging miR-573 to upregulate the expression of E2F transcription factor 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.09.057"}], "href": "https://doi.org/10.1016/j.bbrc.2018.09.057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30309647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30309647"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiang Xiong, Yeqian Feng, Lun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2020.7530"}], "href": "https://doi.org/10.3892/or.2020.7530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32323846"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32323846"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Lin Wang, Guanhua Song, Yabing Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Immunol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cmi.2015.63"}], "href": "https://doi.org/10.1038/cmi.2015.63"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26166764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26166764"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Rui Wang, Boping Wen, Dong Sun "}, {"type": "b", "children": [{"type": "t", "text": "miR-573 regulates cell proliferation and apoptosis by targeting Bax in nucleus pulposus cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Biol Lett (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s11658-018-0132-y"}], "href": "https://doi.org/10.1186/s11658-018-0132-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30936926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30936926"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Song-Shu Lin, Chi-Chien Niu, Li-Jen Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mir-573 regulates cell proliferation and apoptosis by targeting Bax in human degenerative disc cells following hyperbaric oxygen treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-020-02114-6"}], "href": "https://doi.org/10.1186/s13018-020-02114-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33413477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33413477"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shefali Banerjee, Chin Wei Xin, Justin Jang Hann Chu "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 573 Rescues Endothelial Dysfunction during Dengue Virus Infection under PPARγ Regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/jvi.01996-21"}], "href": "https://doi.org/10.1128/jvi.01996-21"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35108097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35108097"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Feifei Zhao, Zhifeng Jia, Yingfa Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dermatol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jdermsci.2021.01.008"}], "href": "https://doi.org/10.1016/j.jdermsci.2021.01.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33648800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33648800"}]}]}]}
Synonyms MIR-573, MIRN573, HSA-MIR-573
NCBI Gene ID 693158
API
Download Associations
Predicted Functions View MIR573's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR573's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR573's ARCHS4 Predicted Functions.

Functional Associations

MIR573 has 614 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.

Click the + buttons to view associations for MIR573 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR573 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR573 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR573 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR573 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR573 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR573 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR573 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR573 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR573 from the GeneSigDB Published Gene Signatures dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR573 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MIR573 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR573 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR573 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of MIR573 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR573 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR573 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR573 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.